The expression of miR-539 in prostate tumors is decreased, contributing to elevated expression of DLX1, which in turn facilitates TGF-β-induced changes in expression of e-cadherin, vimentin, Snail1, and Slug, synonymous with epithelial–mesenchymal transition. The gene discussed is TGFB1; the disease is prostate neoplasm.